Cargando…

Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)

PURPOSE: To determine the pattern of electroretinographic change after an intravitreal ranibizumab (Lucentis(®)) injection for the treatment of choroidal neovascular membrane (CNVM). PATIENTS AND METHODS: A prospective interventional case series of patients treated by intravitreal ranibizumab inject...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhurayanontachai, Patama, Ratanasukon, Mansing, Jirarattanasopa, Pichai
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096619/ https://www.ncbi.nlm.nih.gov/pubmed/21607026 http://dx.doi.org/10.2147/OPTH.S19485

Ejemplares similares

Polypoidal choroidal vasculopathy (PCV): the 4-year review of the real-life treatment experiences
por: Ratanasukon, Mansing, et al.
Publicado: (2018)

High-dose antioxidants for central serous chorioretinopathy; The randomized placebo-controlled study
por: Ratanasukon, Mansing, et al.
Publicado: (2012)

Results of intravitreal dexamethasone implant (Ozurdex(®)) for retinal vascular diseases with macular edema: An observational study of real-life situations
por: Jirarattanasopa, Pichai, et al.
Publicado: (2022)

Visual outcomes of early and late vitrectomy for breakthrough vitreous hemorrhage associated with exudative age-related macular degeneration and polypoidal choroidal vasculopathy
por: Jirarattanasopa, Pichai, et al.
Publicado: (2023)

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
por: Ratanasukon, Mansing, et al.
Publicado: (2013)

The Impact of Vision Impairment (IVI) Questionnaire; Validation of the Thai-Version and the Implementation on Vision-Related Quality of Life in Thai Rural Community
por: Ratanasukon, Mansing, et al.
Publicado: (2016)

Surgical outcomes and prognostic factors following vitrectomy in acquired immune deficiency syndrome patients with cytomegalovirus retinitis-related retinal detachment
por: Sittivarakul, Wantanee, et al.
Publicado: (2020)

The normal choroidal thickness in southern Thailand
por: Jirarattanasopa, Pichai, et al.
Publicado: (2014)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban, Abdallah A, et al.
Publicado: (2012)

One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
por: Pichai, Jirarattanasopa, et al.
Publicado: (2021)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Shah, Nikunj J, et al.
Publicado: (2011)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Pandey, Neeraj, et al.
Publicado: (2013)

Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma
por: Zafar, Sidra, et al.
Publicado: (2016)

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
por: Morris, Rodney J, et al.
Publicado: (2011)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
por: Sun, Tingting, et al.
Publicado: (2021)

Multiple Intravitreal Ranibizumab Injections for Persistant Choroidal Neovascularization Associated with Presumed Ocular Histoplasmosis Syndrome
por: Yılmaz, Turgut, et al.
Publicado: (2017)

Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization
por: Fan, Chuanfeng, et al.
Publicado: (2014)

Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab
por: Kumar, Nitin, et al.
Publicado: (2018)

Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
por: Yun, Cheolmin, et al.
Publicado: (2016)

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
por: Makri, Olga E, et al.
Publicado: (2018)

Retraction notice to “Choroidal osteoma with CNVM – Successful treatment with intravitreal Bevacizumab” [Saudi J Ophthalmol 25 (2011) 199–202]
por: Ayachit, Guruprasad S., et al.
Publicado: (2018)

Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma
por: H.Y. Wu, Zenith, et al.
Publicado: (2012)

The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
por: Kolomeyer, A. M., et al.
Publicado: (2011)

Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment
por: Yin, Houfa, et al.
Publicado: (2016)

Treatment of Punctate Inner Choroidopathy with Choroidal Neovascularization Using Corticosteroid and Intravitreal Ranibizumab
por: Wu, Wei, et al.
Publicado: (2018)

Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
por: Biswas, Partha, et al.
Publicado: (2011)

Long-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child
por: Gupta, Aditi, et al.
Publicado: (2014)

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization
por: Petrou, Petros, et al.
Publicado: (2013)

Intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to morning glory syndrome in a child
por: Özkaya, Abdullah, et al.
Publicado: (2016)

Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization
por: Bhoomibunchoo, Chavakij, et al.
Publicado: (2017)

Simultaneous Single Dexamethasone Implant and Ranibizumab Injection in a Case with Active Serpiginous Choroiditis and Choroidal Neovascular Membrane
por: Saatci, Ali Osman, et al.
Publicado: (2015)

Morphologic Changes in Patient with Drusen and Drusenoid Pigment Epithelial Detachment after Intravitreal Ranibizumab for Choroidal Neovascular Membrane : A Case Report
por: Kim, Sukjin, et al.
Publicado: (2016)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
por: Chen, Shih-Lin, et al.
Publicado: (2021)

Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab
por: Sarıgül Sezenöz, Almila, et al.
Publicado: (2017)

Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent white dots
por: Pece, Alfredo, et al.
Publicado: (2016)

Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
por: Pandey, Neeraj, et al.
Publicado: (2010)

Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
por: Matsumiya, Wataru, et al.
Publicado: (2011)

Intravitreal Ranibizumab in the Treatment of Butterfly-Shaped Pattern Dystrophy Associated with Choroidal Neovascularization: A Case Report
por: Empeslidis, Theodoros, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i4654k1l7v86tlrvc6ia73dkjp